WA
AXDX icon

WFG Advisors’s Accelerate Diagnostics AXDX Stock Holding History

WFG Advisors’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-10
Closed -$2K – 1667
2015
Q1 		$2K Hold
10
– – ﹤0.01% 1521
2014
Q4 		$2K Hold
10
– – ﹤0.01% 1825
2014
Q3 		$2K Hold
10
– – ﹤0.01% 1845
2014
Q2 		$2K Hold
10
– – ﹤0.01% 1807
2014
Q1 		$2K Hold
10
– – ﹤0.01% 1787
2013
Q4 		$1K Hold
10
– – ﹤0.01% 2052
2013
Q3 		$1K Hold
10
– – ﹤0.01% 2010
2013
Q2 		$1K Buy
+10
New +$742 ﹤0.01% 1926

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Private Wealth Advisors
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
MGM
Miura Global Management New York $25.2M AUM 60.6% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Obermeyer Wealth Partners
Obermeyer Wealth Partners Aspen, Colorado $2.44B AUM 24.34% 1-Year Est. Return

WFG Advisors's AXDX Position: Q2 2015 in Review

WFG Advisors sold out of Accelerate Diagnostics (AXDX) in Q2 2015, closing a stake of 10 shares — an estimated $2K sold.

WFG Advisors first reported a position in AXDX in Q2 2013 and held it in 8 quarters. The position peaked at $2K in Q1 2015. 86 funds tracked by Wall St. Rank hold AXDX as of Q2 2015.

  • WFG Advisors reported no remaining Accelerate Diagnostics position as of Q2 2015 after selling out during the quarter.
  • WFG Advisors sold 10 Accelerate Diagnostics shares in Q2 2015, an estimated $2K.
  • WFG Advisors first reported a position in Accelerate Diagnostics in Q2 2013 and held it in 8 quarters.
  • WFG Advisors's Accelerate Diagnostics position peaked at $2K in Q1 2015.
  • 86 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2015.

Based on WFG Advisors's 13F filing for Q2 2015, filed 13 Aug 2015.